샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768562

세계의 체외진단약(IVD) 품질관리 시장

In Vitro Diagnostics (IVD) Quality Control
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 275 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 체외진단약(IVD) 품질관리 시장은 2030년까지 18억 달러에 도달

2024년에 14억 달러로 추정되는 세계의 체외진단약(IVD) 품질관리 시장은 2024-2030년의 분석 기간에 CAGR 5.3%로 성장하며, 2030년에는 18억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 임상화학은 CAGR 6.1%를 기록하며, 분석 기간 종료시에는 6억 760만 달러에 달할 것으로 예측됩니다. 면역화학 분야의 성장률은 분석 기간 중 CAGR 4.6%로 추정됩니다.

미국 시장은 3억 5,080만 달러로 추정, 중국은 CAGR 8.7%로 성장 예측

미국의 체외진단약(IVD) 품질관리 시장은 2024년에는 3억 5,080만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 8.7%로 2030년까지 4억 3,760만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.6%와 4.1%로 예측됩니다. 유럽에서는 독일이 CAGR 3.5%로 성장할 것으로 예측됩니다.

세계의 체외진단약(IVD) 품질관리 시장 - 주요 동향과 촉진요인 정리

체외진단시약(IVD) 품질관리가 정확한 헬스케어 진단에 필수적인 이유는 무엇인가?

체외진단의약품(IVD) 품질관리는 실험실에서 수행되는 진단 검사의 정확성, 신뢰성, 일관성을 보장하는 데 매우 중요한 역할을 합니다. 체외진단용 의약품(IVD) 검사는 질병 진단, 건강 상태 모니터링, 치료 방침 결정에 필수적인 툴입니다. 이러한 검사에는 혈액 검사, 분자진단, 미생물학 검사 등이 포함되며, 다양한 의료 분야에서 사용되고 있습니다. 체외진단용 의약품(IVD)의 품질관리(QC)는 검사 결과의 오류나 불일치를 감지하는 데 도움이 되며, 그렇지 않으면 잘못된 진단이나 치료로 이어질 수 있으므로 매우 중요합니다. 샘플을 통한 검사 성능 모니터링이 포함되며, 진단 결과가 신뢰할 수 있도록 보장합니다.

기술 발전은 IVD 품질관리 시장을 어떻게 형성하고 있는가?

체외진단용 의약품의 품질관리 시장은 기술의 발전으로 인해 큰 변화의 시기를 맞이하고 있습니다. 실험실의 자동화가 점점 더 진행되어 인위적인 실수가 줄어들고 검사 결과의 정확도가 향상되고 있습니다. 다항목 대조군을 포함한 고급 대조물질의 개발로 여러 매개변수를 동시에 모니터링할 수 있는 능력이 향상되어 종합적인 품질 검사가 보장되고 있습니다. 또한 분자진단 및 현장 검사(point-of-care testing)는 빠르게 성장하고 있으며, 이러한 새로운 기술의 복잡성과 특이성에 대응할 수 있는 보다 정교한 품질관리 프로세스의 필요성이 대두되고 있습니다. 또한 AI 기반 데이터 분석이 체외진단 의약품의 품질관리 시스템에 통합되어 실험실에서 잠재적인 문제를 예측하고 실시간으로 프로세스를 조정하여 진단의 신뢰성을 더욱 높일 수 있게 되었습니다.

시장 세분화는 IVD 품질관리 시장의 성장을 어떻게 규정하는가?

제품 유형에는 품질관리 재료, 데이터 관리 소프트웨어, 기기가 포함되며, 품질관리 재료는 다양한 진단 검사에 광범위하게 적용될 수 있으므로 가장 큰 시장 점유율을 차지하며, IVD 품질관리 용도에는 임상화학, 면역측정, 혈액학, 분자진단학이 포함되며, 개인화된 의료 및 유전자 검사가 확산됨에 따라 분자진단학이 가장 빠르게 성장하고 있습니다. 의 보급으로 분자진단학이 가장 빠르게 성장하고 있습니다. 최종사용자에는 병원, 임상검사실, 학술 및 연구기관이 포함되며, 임상검사실은 검사량이 많고 일관되고 신뢰할 수 있는 결과가 매우 중요하므로 가장 큰 부문입니다. 시장도 전 세계에서 확대되고 있으며, 북미와 유럽이 도입을 주도하고 있는 반면, 아시아태평양은 헬스케어 인프라 투자 증가로 인해 빠르게 성장하고 있습니다.

IVD 품질관리 시장의 성장을 가속하는 요인은 무엇인가?

IVD 품질관리 시장의 성장은 정확한 진단에 대한 수요 증가, 만성질환 및 감염성 질환 증가, 진단 정확도에 대한 엄격한 규제 요건 등 여러 가지 요인에 의해 이루어집니다. 의료 시스템이 더 나은 결과를 제공하기 위해 노력하는 가운데 정확한 진단 툴의 필요성이 가장 중요하며, 검사 기관은 견고한 품질관리 조치에 투자해야 합니다. 또한 암, 당뇨병, 심혈관 질환과 같은 질병의 유병률 증가도 진단 검사에 대한 수요 증가에 기여하고 있으며, IVD의 품질관리의 필요성을 높이고 있습니다. 또한 FDA, 유럽의약품청(EMA) 등 규제기관은 환자의 안전과 검사의 신뢰성을 보장하기 위해 엄격한 QC를 시행하도록 의무화하고 있으며, 이는 시장 성장을 더욱 촉진하고 있습니다.

부문

용도(임상화학, 면역화학, 분자진단, 혈액학, 기타 용도), 최종 용도(병원, 임상 검사실, 기타 최종 용도)

조사 대상 기업의 예

  • Abbott Laboratories
  • Becton, Dickinson And Company(BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol B.V.
  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.17

Global In Vitro Diagnostics (IVD) Quality Control Market to Reach US$1.8 Billion by 2030

The global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$607.6 Million by the end of the analysis period. Growth in the Immunochemistry segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$350.8 Million While China is Forecast to Grow at 8.7% CAGR

The In Vitro Diagnostics (IVD) Quality Control market in the U.S. is estimated at US$350.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$437.6 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global In Vitro Diagnostics (IVD) Quality Control Market - Key Trends and Drivers Summarized

Why Is In Vitro Diagnostics (IVD) Quality Control Critical for Accurate Healthcare Diagnostics?

In Vitro Diagnostics (IVD) quality control plays a pivotal role in ensuring the accuracy, reliability, and consistency of diagnostic tests performed in laboratories. IVD tests are essential tools for diagnosing diseases, monitoring health conditions, and guiding treatment decisions. These tests include blood tests, molecular diagnostics, and microbiological assays, and they are used across various medical disciplines. Quality control (QC) measures in IVD are crucial because they help detect errors or inconsistencies in test results, which could otherwise lead to incorrect diagnoses or treatments. QC in IVD involves the regular calibration of diagnostic equipment, validation of test procedures, and monitoring of test performance through control samples, ensuring that the diagnostic outcomes are reliable and trustworthy.

How Are Technological Advancements Shaping the IVD Quality Control Market?

The IVD quality control market is undergoing significant transformation, thanks to advancements in technology. Automation in laboratories is increasingly being adopted, reducing human error and improving the accuracy of test results. The development of advanced control materials, including multi-analyte controls, has improved the ability to monitor multiple parameters simultaneously, ensuring comprehensive quality checks. Additionally, molecular diagnostics and point-of-care testing are growing rapidly, leading to the need for more sophisticated quality control processes that can handle the complexity and specificity of these newer technologies. Moreover, AI-driven data analysis is being integrated into IVD quality control systems, enabling laboratories to predict potential issues and adjust processes in real-time, further enhancing the reliability of diagnostics.

How Do Market Segments Define the Growth of the IVD Quality Control Market?

Product types include quality control materials, data management software, and instruments, with quality control materials holding the largest market share due to their wide applicability in various diagnostic tests. Applications of IVD quality control include clinical chemistry, immunoassay, hematology, and molecular diagnostics, with molecular diagnostics witnessing the fastest growth as personalized medicine and genetic testing gain traction. End-users include hospitals, clinical laboratories, and academic and research institutions, with clinical laboratories being the largest segment due to their high volume of testing and the critical need for consistent, reliable results. The market is also expanding globally, with North America and Europe leading in adoption, while the Asia-Pacific region is experiencing rapid growth due to increasing healthcare infrastructure investments.

What Factors Are Driving the Growth in the IVD Quality Control Market?

The growth in the IVD quality control market is driven by several factors, including the increasing demand for accurate diagnostics, the rising prevalence of chronic and infectious diseases, and stringent regulatory requirements for diagnostic accuracy. As healthcare systems strive to provide better outcomes, the need for precise diagnostic tools is paramount, pushing laboratories to invest in robust quality control measures. The increasing incidence of diseases such as cancer, diabetes, and cardiovascular conditions is also contributing to higher demand for diagnostic tests, thus driving the need for quality control in IVD. Furthermore, regulatory agencies such as the FDA and the European Medicines Agency (EMA) have implemented stricter guidelines, mandating rigorous QC practices to ensure patient safety and test reliability, further fueling market growth.

SCOPE OF STUDY:

The report analyzes the In Vitro Diagnostics (IVD) Quality Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology, Other Applications); End-Use (Hospitals, Clinical Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson And Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol B.V.
  • F. Hoffmann -La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • In Vitro Diagnostics (IVD) Quality Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Point-of-Care Testing Propels Demand for IVD Quality Control
    • Growing Incidence of Chronic Diseases Spurs Need for Reliable Diagnostics
    • Technological Innovations in Molecular Diagnostics Expands Market Potential
    • Automation and AI Integration Strengthens Business Case for IVD Quality Control
    • Heightened Focus on Personalized Medicine Propels Adoption of Precision Diagnostics
    • Rising Awareness of Preventive Healthcare Accelerates Demand for IVD Testing
    • Adoption of Companion Diagnostics Expands Addressable Market
    • Advancements in Multiplex Assays Generates Opportunities for Enhanced Accuracy
    • Stringent Quality Standards in Healthcare Fuel Investments in IVD Quality Control
    • Growth of Telemedicine Strengthens Demand for Remote Diagnostic Solutions
    • Focus on Reducing Diagnostic Errors Expands Adoption of Quality Control Measures
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World In Vitro Diagnostics (IVD) Quality Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제